कंपनी का अवलोकन
USANA Health Sciences, Inc. operates within the consumer defensive sector, specifically functioning in the packaged foods industry, where it develops, manufactures, and sells science-based nutritional, personal care, and skincare products across the Asia Pacific, the Americas, and Europe. The company utilizes two primary operational segments, Core nutritional and Hiya Direct-To-Consumer, to distribute its range of USANA nutritional optimizers and related health products. This entity maintains a workforce of 1570 employees, indicating a moderate organizational scale relative to the broader consumer staples landscape. With a market capitalization of $333.52M and annual revenue of $925.26M, the company holds a position that suggests it is a specialized player rather than a dominant market leader, reflecting a niche focus within the global packaged goods market.
वित्तीय स्वास्थ्य
The company reported total revenue of $925.26M over the trailing twelve months, generating net income of $10.76M and EBITDA of $83.42M, which highlights a significant disparity between gross revenue and final profit attributable to shareholders. The substantial gap between the $925.26M revenue and the $10.76M net income reveals a cost structure characterized by high operating expenses that consume a large portion of top-line earnings before reaching the bottom line. Free cash flow stands at $36.85M, providing the organization with essential financial flexibility to fund operations, manage working capital, or pursue strategic initiatives without immediate reliance on external financing. Gross margin is reported at 78.3%, indicating strong pricing power or efficient production costs, while operating margin sits at 7.6% and profit margin at 1.2%, suggesting that significant costs related to distribution, sales commissions, or general administration impact the final profitability. The company holds $158.38M in cash against $31.96M in debt, resulting in a debt-to-equity ratio of 5.45, which presents a mixed picture of high leverage relative to equity but a robust net cash position. The current ratio of 2.24 indicates a conservative approach to short-term liquidity, as the company possesses more than twice the current assets needed to cover its current liabilities. Furthermore, return on equity is 2.0% and return on assets is 4.3%, metrics that reveal management effectiveness is currently challenged by the high leverage and the thin profit margins inherent in the business model.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is 31.16, while the forward P/E is 6.52, a stark difference that implies market expectations for a dramatic improvement in earnings trajectory or a significant disconnect between current profitability and future projections. The price-to-book ratio stands at 0.62, indicating that the market values the company at a substantial discount to its book value, which may reflect concerns about the quality of assets or the low return on equity. Alternative valuation metrics such as the price-to-sales ratio of 0.36 and an EV/EBITDA of 3.12 suggest the stock is priced on a very low multiple relative to its sales volume and earnings before interest, taxes, depreciation, and amortization. The 52-week price range spans from a low of $16.60 to a high of $38.32, meaning the stock has experienced significant volatility within the past year. The beta value is 0.70, which indicates that the stock's price volatility is lower than the broader market, making it less sensitive to general market movements.
Growth & Income
Revenue growth year-over-year is recorded at 5.9%, whereas earnings growth is marked as N/A due to the reported net income figures, preventing a direct comparison of earnings expansion relative to top-line growth. Since the company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it retains all generated earnings to reinvest into business growth, research, or debt management rather than distributing income to shareholders. This reinvestment strategy prioritizes capital allocation for operational expansion over providing immediate cash returns to investors. The overall growth and income profile is defined by modest revenue expansion without dividend support, relying entirely on capital appreciation potential driven by the company's ability to improve its thin profit margins and manage its significant leverage.